Copyright
©The Author(s) 2022.
World J Methodol. Jul 20, 2022; 12(4): 200-223
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.200
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.200
The age and sex of the patients |
The type of the autoimmune disease |
The severity of the autoimmune disease. |
Presence of comorbidities |
The type of medication used |
Disruption of the medical care continuity |
Lack of medication adherence |
Other factors that increase COVID-19 severity in the general population |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS. COVID-19 disease and autoimmune disorders: A mutual pathway. World J Methodol 2022; 12(4): 200-223
- URL: https://www.wjgnet.com/2222-0682/full/v12/i4/200.htm
- DOI: https://dx.doi.org/10.5662/wjm.v12.i4.200